Home/Filings/4/0001367644-22-000043
4//SEC Filing

Havey Adam 4

Accession 0001367644-22-000043

CIK 0001367644other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 7:25 PM ET

Size

10.8 KB

Accession

0001367644-22-000043

Insider Transaction Report

Form 4
Period: 2022-02-28
Havey Adam
EVP, BioDefense Division
Transactions
  • Award

    Employee Stock Options (Right to Buy)

    2022-03-01$41.38/sh+42,289$1,749,91942,289 total
    Exercise: $41.38Exp: 2029-02-28Common Stock (42,289 underlying)
  • Award

    Common Stock

    2022-03-01+17,82286,939 total
  • Award

    Common Stock

    2022-03-01+32,32369,117 total
  • Tax Payment

    Common Stock

    2022-02-28$39.64/sh739$29,29486,200 total
Footnotes (4)
  • [F1]Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (10,573 shares) or on the day prior to the second anniversary date of the grant (21,750 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
  • [F2]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
  • [F3]Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.
  • [F4]Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company.

Issuer

Emergent BioSolutions Inc.

CIK 0001367644

Entity typeother

Related Parties

1
  • filerCIK 0001514588

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:25 PM ET
Size
10.8 KB